Nucleus Genomics raised $14M in a Series A led by Founders Fund to advance its genetic testing technology.

Jan 30, 2025•7 months ago

Amount Raised

$14 Million

Round Type

series a

New YorkBiotechnology

Investors

Achal UpadhyayaBalaji SrinivasanAlexis Ohanian’s Seven Seven SixFounders Fund

Description

Nucleus Genomics has successfully secured $14 million in a Series A funding round. This investment, supported by notable investors including Alexis Ohanian's Seven Seven Six, will help the company enhance its genetic testing services.

Company Information

Company

Nucleus Genomics

Location

New York, New York, United States

About

Nucleus is an advanced DNA health test that takes the guesswork out of healthcare, whether it’s knowing your risk for cancer or planning for a healthy family. Genomic testing has always been fragmented— there are over 70,000 genetic tests on the market today, each analyzing different genes or markers. Our technology combines all these tests into one to analyze your risk for over 800 conditions with a single swab.

Related People

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends